Bharat Biotech Ltd., a prominent player in the biotechnology sector, is headquartered in Hyderabad, India. Founded in 1996, the company has established itself as a leader in vaccine development and biopharmaceuticals, focusing on innovative solutions for infectious diseases. With a robust portfolio that includes vaccines for diseases such as typhoid, hepatitis, and COVID-19, Bharat Biotech is renowned for its commitment to research and development. The company’s unique approach combines cutting-edge technology with a strong emphasis on safety and efficacy, setting it apart in the competitive landscape. Recognised for its significant contributions to public health, Bharat Biotech has achieved notable milestones, including the development of India’s first indigenous COVID-19 vaccine. Its strategic operations extend across various regions, reinforcing its position as a key player in the global biotechnology industry.
How does Bharat Biotech Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bharat Biotech Ltd.'s score of 14 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bharat Biotech Ltd., headquartered in India, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. As of now, Bharat Biotech has not cascaded any emissions data from a parent or related organization, indicating that their climate commitments and emissions reporting are independent. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the broader context of the biotechnology industry, companies are increasingly recognising the importance of sustainability and are setting ambitious targets to reduce their carbon footprints. Bharat Biotech may benefit from aligning with industry standards and practices to enhance its climate commitments in the future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bharat Biotech Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.